dobutamine has been researched along with pimobendan in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Futaki, S; Goto, Y; Hata, K; Kawaguchi, O; Nishioka, T; Ohgoshi, Y; Saeki, A; Takasago, T; Taylor, TW; Yaku, H | 1 |
| Abe, Y; Kitada, Y; Narimatsu, A | 1 |
| Abiko, Y; Ichihara, K | 1 |
| Baumann, G; Ningel, K; Permanetter, B | 2 |
| Hanzawa, K; Kamiyama, Y; Murayama, K; Shiraishi, M; Warabi, K | 1 |
| Erdmann, E | 1 |
| Goto, Y; Hata, K | 1 |
| Asanoi, H; Inoue, H; Ishizaka, S; Joho, S; Kameyama, T | 1 |
| Boldt, J; Kirchner, J; Lehmann, A | 1 |
| Day, J; Duchaussoy, AC; Hughes, D | 1 |
2 review(s) available for dobutamine and pimobendan
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
The role of Ca++-sensitizers for the treatment of heart failure.
Topics: Calcium; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Myocardial Ischemia; Pyridazines; Simendan | 2003 |
2 trial(s) available for dobutamine and pimobendan
| Article | Year |
|---|---|
Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Topics: Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Nitroprusside; Pulmonary Circulation; Pyridazines; Receptors, Adrenergic, beta; Stroke Volume; Time Factors; Vascular Resistance; Vasodilator Agents | 1989 |
Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
Topics: Adult; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Chronic Disease; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Myocardial Contraction; Nitroprusside; Pulmonary Artery; Pulmonary Wedge Pressure; Pyridazines; Receptors, Adrenergic, beta; Stroke Volume; Time Factors; Vascular Resistance | 1989 |
8 other study(ies) available for dobutamine and pimobendan
| Article | Year |
|---|---|
Mechanoenergetic effects of pimobendan in canine left ventricles. Comparison with dobutamine.
Topics: Animals; Blood Pressure; Blood Volume; Dobutamine; Dogs; Energy Metabolism; Heart Arrest, Induced; Heart Ventricles; Myocardial Contraction; Myocardium; Oxygen Consumption; Potassium Chloride; Propranolol; Pyridazines; Ventricular Function, Left | 1992 |
Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
Topics: Acidosis; Animals; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Hydrogen-Ion Concentration; Male; Milrinone; Myocardial Contraction; Pyridazines; Pyridones | 1992 |
The effect of pimobendan on myocardial mechanical function and metabolism in dogs: comparison with dobutamine.
Topics: Adenine Nucleotides; Animals; Cardiotonic Agents; Dobutamine; Dogs; Female; Hemodynamics; Injections, Intravenous; Male; Myocardial Contraction; Myocardium; Pyridazines | 1991 |
[Epidural anesthesia for herniorrhaphy in a patient with severe dilated cardiomyopathy (DCM) under pimobendan control].
Topics: Anesthesia, Epidural; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Dopamine; Fentanyl; Heart Failure; Hernia, Inguinal; Humans; Hypotension; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Pyridazines | 1997 |
The effect of positive inotropes on the failing human myocardium.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Calcium; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Milrinone; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones | 1997 |
Mechanoenergetic effect of pimobendan in failing dog hearts.
Topics: Animals; Cardiac Output, Low; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; In Vitro Techniques; Myocardial Contraction; Oxygen Consumption; Pyridazines; Ventricular Function, Left; Ventricular Pressure | 1997 |
Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Cardiotonic Agents; Dobutamine; Dogs; Heart Failure; Heart Rate; Myocardial Contraction; Pyridazines; Stimulation, Chemical; Stroke Volume; Tachycardia; Ventricular Pressure | 2002 |
What Is Your Diagnosis? Dilated cardiomyopathy.
Topics: Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Cat Diseases; Cats; Diuretics; Dobutamine; Furosemide; Male; Pyridazines; Taurine | 2015 |